Evidence map›Paper›PMID 36504055›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2022

[Galectin-1 knockdown inhibits proliferation, migration, invasion and promotes apoptosis of lung adenocarcinoma cells

W Chen, X Zhu, S Zhou, F Xing, Z Tang, X Li, L Zhang

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

W ChenAnhui Provincial Key Laboratory of Translational Cancer Medicine, Bengbu 233004, China.
X ZhuDepartment of Thoracic Surgery, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
S ZhouDepartment of Thoracic Surgery, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
F XingDepartment of Thoracic Surgery, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
Z TangDepartment of Thoracic Surgery, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
X LiDepartment of Thoracic Surgery, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
L ZhangDepartment of Thoracic Surgery, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
Bengbu Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the effect of galectin-1 on biological behaviors of lung adenocarcinoma cells and the underlying mechanism.

methodsThe expression levels of galectin-1 mRNA were detected in 8 pairs of lung adenocarcinoma tissues and adjacent normal tissues and in lung adenocarcinoma cell lines A549 and H1299 and normal bronchial epithelial cell line BEAS-2b using qRT-PCR. The effect of galectin-1 knockdown by RNA interference on the proliferation, invasion and migration abilities and apoptosis of lung adenocarcinoma cells were examined using CCK8 assay, Transwell assay, scratch assay and flow cytometry. Western blotting was performed to detect the expressions of apoptosis-related proteins BAX, BCL-2, and caspase-3 and the proteins involved in the AKT and ERK pathways.

resultsThe mRNA expression of galectin-1 was significantly increased in lung cancer tissues and lung adenocarcinoma cell lines (

conclusionGalectin-1 knockdown inhibits proliferation, migration, and invasion and promotes apoptosis of lung adenocarcinoma cells, and this effect is mediated probably by inhibition of the phosphorylation levels of the ERK pathway.

Indexed as

Adenocarcinoma of LungLung NeoplasmsApoptosisCell ProliferationHumansMAP Kinase Signaling SystemapoptosisERK signaling pathwaygalectin-1invasionlung adenocarcinomamigrationproliferation

Identifiers

PMID36504055
PMCPMC9742775
OpenAlexW4311666200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.